ESR1 and breast cancer: Several studies demonstrated that age of patients with breast cancer at diagnosis, BMI, tumor size, primary tumor quadrant, presence of multiple tumors, clinical lymph node status, local invasion status, pathological type, ER/PR, HER2 status, molecular subtypes, and other factors were related to ALN metastasis status [35–37].